Documents & Downloads

7β,16α-Dihydroxybufalin

Bufalin Derivative

7β,16α-Dihydroxybufalin is a dihydroxylated derivative of bufalin that targets cancer cell lines with notable cytotoxic activity. This compound is utilized in research focusing on cancer therapeutics and offers potential insights into antitumor mechanisms and drug development. Its structure and biological effects make it a valuable tool for studies investigating the efficacy of bufalin derivatives in cancer treatment.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	773133-78-1
Applications	Bufalin Derivative
Formula	C₂₄H₃₄O₆
Molecular Weight	418.52
SMILES	O[C@@]12[C@@]3([H])[C@@](CC[C@@]1([C@@H](C(C=C4)=COC4=O)[C@@H](C2)O)C)([H])[C@@]5([C@](C[C@H](CC5)O)([H])C[C@@H]3O)C

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.